脑部放疗，上午比下午敏感许多！
$ a1 j- \8 ]( v4 I m0 R3 Z% B9 X$ F/ D d. Q
7 r1 R& |0 S2 s1 g+ Q& ^# KCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.) W! P- j* g( f! @* V
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?9 D2 T7 e$ P, M# U
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
: Z$ F+ w$ D$ _2 k) ?/ P- @/ pSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
/ l }& ], m l3 j$ }
% u) ~; o3 N! X- J' C bAbstract
' P; C |4 c- ?, M+ ^BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.2 _! d1 m" P, s) c: o# }
) f9 h6 O! A5 t
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.# |* s8 T4 h" W' A2 X: V2 p
! P; Q1 W4 @( N- }, @
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026). ~2 O. J$ M$ ~/ @0 q% y( k
% X9 w t. \ P; j8 ]$ d) ~, g6 R
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.5 y/ ~2 I, z2 L
: M& j5 `2 V' a9 D) c) I% v |
5 w6 Z( `" w/ L# B' l
显身卡
